In this undated photo released by Pfizer on Tuesday, Dec. 1, 2020, a thermal shipping box for a COVID-19 candidate vaccine developed by BioNTech and Pfizer is shown in front of a freezers at the company headquarters in Puurs, Belgium. The potential vaccine is awaiting approval to use against the coronavirus. (Pfizer via AP)

In this undated photo released by Pfizer on Tuesday, Dec. 1, 2020, a thermal shipping box for a COVID-19 candidate vaccine developed by BioNTech and Pfizer is shown in front of a freezers at the company headquarters in Puurs, Belgium. The potential vaccine is awaiting approval to use against the coronavirus. (Pfizer via AP)

UK becomes first to authorize Pfizer coronavirus vaccine for emergency use

U.K. will begin receiving the first shipment of 800,000 doses of the Pfizer-BioNTech vaccine ‘within days’

Britain authorized a COVID-19 vaccine for use Wednesday, greenlighting the first shot backed up by rigorous scientific review. The first vaccinations are expected within days — a major step toward eventually ending the pandemic.

The go-ahead for the vaccine from American drugmaker Pfizer and Germany’s BioNTech comes as the virus surges again in the United States and Europe, putting pressure on hospitals and forcing new rounds of restrictions that have devastated the global economy. Officials cautioned that several tough months still lie ahead, even in Britain, given the scale of the operation needed to vaccinate large swaths of the population.

The Medicines and Healthcare Products Regulatory Agency, which licenses drugs in the U.K., recommended the vaccine for emergency use after it reviewed a raft of data, including the results of clinical trials that showed it was 95% effective and offered significant protection for older people, among those most at risk of dying from the disease. But the vaccine remains experimental while final testing is done.

“This is, without any shadow of a doubt, an historic day,” said David Harper, senior consulting fellow in global health at the Chatham House think-tank . “This is an unprecedented piece of science,” given that the vaccine was authorized less than a year after COVID-19 was discovered.

Other countries aren’t far behind: Regulators in the United States and the European Union also are vetting the Pfizer vaccine along with a similar shot made by competitor Moderna Inc. British regulators also are considering another shot made by AstraZeneca and Oxford University.

British Health Secretary Matt Hancock said the U.K. will begin receiving the first shipment of 800,000 doses of the Pfizer-BioNTech vaccine “within days,” and people will start getting the shots as soon as it arrives. Two doses three weeks apart are required for protection.

The U.K. expects to receive “millions of doses” by the end of this year, Hancock said, adding that the exact number will depend on how fast it can be manufactured and checked for quality.

“The doses that we have for the U.K. are currently being packed (by) our colleagues at Pfizer’s facility in Belgium, ready for shipping very, very quickly,” BioNTech’s chief commercial officer, Sean Marett, told reporters Wednesday.

But doses are scarce as production ramps up. BioNTech, which owns the vaccine, has so far signed deals to supply 570 million doses worldwide in 2021, with options to deliver 600 million more, Marett said. It hopes to supply at least 1.3 billion in 2021.

The German company has partnered with Pfizer to deliver the vaccine worldwide, except in China where local company Fosun Pharma will handle distribution.

The BioNTech figures still only represent a fraction of what will be needed as public health officials try to vaccinate much of the world’s population. Experts have said that several vaccines will be needed in order to quickly end the pandemic, which has killed more than 1.4 million people worldwide.

In Britain, public health officials plan to offer the vaccine first to those who are most at risk of dying from the disease and those whose jobs put them at risk of contracting the virus and spreading it to others. The vaccination program will be expanded to others as supplies become available.

The first vaccines will go to nursing home residents and those who care for them, followed by everyone over 80, and healthcare workers. From there, government plans call for vaccines to be offered roughly on the basis of age groups, starting with the oldest people first.

The drugmakers said they would immediately begin shipping limited supplies to the U.K. — and have been gearing up for wider distribution if the shot receives approval from the U.S. Food and Drug Administration, a decision expected as early as next week.

Despite the speed with which they approved the vaccine, British regulators insisted “no corners have been cut” during the review process.

The MHRA made its recommendation following a rolling review of that allowed it to assess information about the vaccine as soon as it became available. The agency began analysis of preclinical data in October, followed by information on manufacturing and quality assurance and finally the results of the clinical trials.

“The safety of the public will always come first,” Dr. June Raine, chief executive of the agency, said during a news conference. “And I emphasize again that this recommendation has only been given by the MHRA following the most rigorous scientific assessment of every piece of data.”

Getting that message to the public will be critical if any vaccination program is to be successful. Some people are worried about getting any vaccine, never mind a new one.

Jacqueline Roubians, a retired nurse, hopes most people will get the shot.

“A lot of people are skeptical but I think once they understand and see everyone else having it without hesitation, I think you’ll find that people will go and have it,” Roubians, 76, said at Brixton Market in London. “People are dying of COVID, so you make that decision: do you want to die or do you want the vaccine?”

In addition to massive logistical challenge of distributing billons of vaccines, the Pfizer-BioNTech one must be stored and shipped at ultra-cold temperatures of around minus 70 degrees Celsius (minus 94 degrees Fahrenheit).

Pfizer says it has developed shipping containers that use dry ice to keep the vaccine cool. GPS-enabled sensors will allow the company to track each shipment and ensure they stay cold.

The company also says it has agreed to work with other vaccine makers to ensure there is sufficient supply and a range of vaccines, “including those suitable for global access.”

Every country has different rules for determining when an experimental vaccine is safe and effective enough to use. Intense political pressure to be the first to roll out a rigorously scientifically tested shot colored the race in the U.S. and Britain, even as researchers pledged to cut no corners.

In contrast, China and Russia have offered different vaccinations to their citizens ahead of late-stage testing.

The vaccine made by Pfizer and BioNTech was tested in tens of thousands of people. And while the study isn’t complete, early results suggest the vaccine is 95% effective at preventing mild to severe COVID-19 disease. The companies told regulators that of the first 170 infections detected in study volunteers, only eight were among people who’d received the actual vaccine and the rest had gotten a dummy shot.

The companies also reported no serious side effects, although vaccine recipients may experience temporary pain and flu-like reactions immediately after injections.

Still to be determined is whether the shots protect against people spreading the coronavirus without showing symptoms. Another question is how long protection lasts.

The vaccine also has been tested in only a small number of children, none younger than 12, and there’s no information on its effects in pregnant women.

READ MORE: Ottawa must be more transparent regarding COVID-19 vaccine rollout: expert

___

Neergaard reported from Alexandria, Virginia. Associated press writers Frank Jordans in Berlin and Jill Lawless, Pan Pylas and Jo Kearney in London contributed

__

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Lauran Neergaard And Danica Kirka, The Associated Press


Like us on Facebook and follow us on Twitter.

Want to support local journalism during the pandemic? Make a donation here.

Coronavirusvaccines

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

county
County of Paintearth highlights from Jan. 12th

County graders have been out blading ice at intersections where ice buildup has been bad

Alberta has 3,651 active cases of COVID-19.  (File photo)
750 new COVID-19 cases identified in Alberta Sunday

Central zone currently has 1,182 active cases of the virus

The Pfizer-BioNTech vaccine deliveres to Canada are being delayed because of complications at their European distribution facility. THE CANADIAN PRESS/Nathan Denette
Delays of Pfizer vaccine delivery to impact Alberta’s vaccination plans

Alberta has administered 74,000 doses of the COVID-19 vaccine so far

ski
Valley Ski Club Slope Stabilization Project is awarded CFEP Grant

With forecasts predicting continued mild weather, the board made the decision not to proceed with the current season

A scene from “Canada and the Gulf War: In their own words,” a video by The Memory Project, a program of Historica Canada, is shown in this undated illustration. THE CANADIAN PRESS/HO - Historica Canada
New video marks Canada’s contributions to first Gulf War on 30th anniversary

Veterans Affairs Canada says around 4,500 Canadian military personnel served during the war

(Phil McLachlan - Black Press Media)
RCMP say ice climber seriously injured after reportedly falling 12 metres near Abraham Lake

Police say man’s injuries were serious but not life-threatening

Indigenous people gather for a ceremony for Cindy Gladue held at the courthouse in Edmonton, Alta, on Wednesday, January 13, 2021. Bradley Barton, a 52-year-old long-haul truck driver from Ontario on trial for manslaughter, is accused of killing Gladue. THE CANADIAN PRESS/Jason Franson
People stand in support of mother as new trial gets underway in death of Cindy Gladue

Bradley Barton, a long-haul truck driver from Ontario, will now be tried for manslaughter in the 2011 death

U.S. military units march in front of the Capitol, Monday, Jan. 18, 2021 in Washington, as they rehearse for President-elect Joe Biden’s inauguration ceremony, which will be held at the Capitol on Wednesday. (AP Photo/J. Scott Applewhite)
Biden aims for unifying speech at daunting moment for U.S.

President Donald Trump won’t be there to hear it

Facebook/ The Open Door 24/7 Integrated Response Hub- Wetaskiwin.
Wetaskiwin residents show support for 24/7 Integrated Response Hub

Wetaskiwin residents and City Council members showed support for Hub with positive signs.

Conservative Leader Erin O’Toole holds a press conference on Parliament Hill, in Ottawa on December 10, 2020. THE CANADIAN PRESS/Sean Kilpatrick
No place for ‘far right’ in Conservative Party, Erin O’Toole says

O’Toole condemned the Capitol attack as ‘horrifying’ and sought to distance himself and the Tories from Trumpism

A passer by walks in High Park, in Toronto, Thursday, Jan. 14, 2021. This workweek will kick off with what’s fabled to be the most depressing day of the year, during one of the darkest eras in recent history. THE CANADIAN PRESS/Chris Young
‘Blue Monday’ getting you down? Exercise may be the cure, say experts

Many jurisdictions are tightening restrictions to curb soaring COVID-19 case counts

A health-care worker prepares a dose of the Pfizer-BioNTech COVID-19 vaccine at a UHN COVID-19 vaccine clinic in Toronto on Thursday, January 7, 2021. THE CANADIAN PRESS/Nathan Denette
COVID-19: Provinces work on revised plans as Pfizer-BioNTech shipments to slow down

Anita Anand said she understands and shares Canadians’ concerns about the drug company’s decision

Prime Minister Justin Trudeau listens to a question during a news conference outside Rideau cottage in Ottawa, Friday, January 8, 2021. THE CANADIAN PRESS/Adrian Wyld
Trudeau says Canada’s COVID vaccine plan on track despite Pfizer cutting back deliveries

Canadian officials say country will still likely receive four million doses by the end of March

Most Read